LOC441294 Activators encompass a variety of chemical compounds that indirectly augment the functional activity of LOC441294 through several signaling pathways. Forskolin, known for its ability to elevate intracellular cAMP levels, indirectly enhances LOC441294's functional role by activating PKA, which can phosphorylate substrates that participate in the signaling pathways involving LOC441294. Similarly, Resveratrol and Nicotinamide riboside both activate sirtuin proteins, which are known to deacetylate key proteins that could be involved in LOC441294-mediated processes, hence indirectly enhancing LOC441294 activity. The polyphenol Curcumin modulates the NF-κB pathway, known to intersect with signaling pathways relevant to LOC441294, thus potentially enhancing its functional activity. The action of Sphingosine-1-phosphate on its receptors initiates downstream signaling events that might potentiate the functions of LOC441294, while Epigallocatechin gallate, by inhibiting competitive kinase signaling, could shift cellular signaling dynamics in favor of LOC441294 activity.
In addition to these, Piperlongumine boosts reactive oxygen species (ROS) levels, which can have widespread effects on cellular signaling, potentially enhancing the pathways in which LOC441294 is involved. Anandamide activates endocannabinoid receptors, which are part of a complex signaling network that could intersect with LOC441294 signaling pathways. Capsaicin, through the activation of TRPV1, may trigger signaling cascades that enhance LOC441294 activity. Sodium orthovanadate, by inhibiting protein tyrosine phosphatases, could modulate phosphorylation events that affect LOC441294 signaling. IBMX raises cAMP levels similar to Forskolin, which also leads to PKA activation and potential enhancement of LOC441294. Lastly, Lithium chloride inhibits GSK-3 within the Wnt signaling pathway, which may intersect with and enhance LOC441294-related signaling pathways, leading to increased functional activity of LOC441294 without the need for upregulation of its expression or direct activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Activates SIRT1, which can deacetylate proteins involved in the signaling pathway of LOC441294, indirectly enhancing its activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates NF-κB pathway which may intersect with LOC441294 activity, leading to its functional enhancement. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P receptor activation can initiate signaling cascades that potentiate the functions in which LOC441294 is involved. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
As a kinase inhibitor, EGCG may alleviate competitive signaling pathways, thereby potentially enhancing LOC441294 activity. | ||||||
Piperlongumine | 20069-09-4 | sc-364128 | 10 mg | $107.00 | ||
Increases ROS levels which can modulate signaling pathways associated with LOC441294, indirectly increasing its activity. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
TRPV1 agonist that can activate intracellular pathways potentially leading to the enhancement of LOC441294 function. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibits tyrosine phosphatases, which may shift the balance of phosphorylation events affecting LOC441294 activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective inhibitor of phosphodiesterases, raises cAMP levels which can indirectly enhance LOC441294 activity via PKA activation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Glycogen synthase kinase-3 (GSK-3) inhibitor, which could modulate Wnt signaling intersecting with LOC441294 pathways. | ||||||